Design and subject characteristics in the federally-funded citalopram trial in children with pervasive developmental disorders.
Scahill L, McCracken JT, Bearss K, Robinson F, Hollander E, King B, Bregman J, Sikich L, Dukes K, Sullivan L, Anagnostou E, Donnelly C, Kim YS, Ritz L, Hirtz D, Wagner A.
Scahill L, et al. Among authors: anagnostou e.
J Autism Dev Disord. 2012 Mar;42(3):432-40. doi: 10.1007/s10803-011-1251-8.
J Autism Dev Disord. 2012.
PMID: 21667200
Clinical Trial.